|
(Health-NewsWire.Net, July 07, 2021 ) This report aims to provide detailed insights into the global neuroendoscopy market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.
Revenue Growth Analysis:
The global neuroendoscopy market is expected to reach USD 218.9 Million by 2022 from USD 170.5 Million in 2017, at a CAGR of 5.1%.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=68126508
Neuroendoscopy procedures are increasingly being used for the treatment of a number of neurological disorders, such as pineal region tumors, pituitary tumors, Rathke's cleft cysts, skull base tumors, and ventricular tumors. Its use is also growing in neuro-oncology, conducting brain biopsies, and the treatment of hydrocephalus.
Key Factors Driving Market Growth:
The growth of the Brain Surgery Market is attributed to favorable government initiatives, rising prevalence of neurological disorders, and benefits of neuroendoscopic surgery over conventional brain surgery.
Rigid neuroendoscopes dominated the market in 2017.
Based on product, the Neuroendoscopy Market is segmented into rigid neuroendoscopes and flexible neuroendoscopes. The rigid neuroendoscopy segment is further classified into rigid videoscopes and rigid fiberscopes. In 2017, the rigid neuroendoscopes segment accounted for the largest share of the Neuroendoscopy Devices market. This large share can be attributed to their reduced size, affordable pricing, and shock resistance.
Based on application, the transcranial neuroendoscopy segment is projected to grow at the highest CAGR during the forecast period.
Based on application, the Neuroendoscopy Market is segmented into intraventricular neuroendoscopy, transcranial neuroendoscopy, and transnasal neuroendoscopy. The transcranial segment is expected to register the highest CAGR during the forecast period. The growth of this segment can be attributed to their wide application in the diagnosis and treatment of larger tumors with significant suprasellar extension and growing incidence of brain tumors in the population.
North America dominated the Neuroendoscopy Industry in 2017
In 2017, North America dominated the market followed by Europe. The large share of this geographical segment is attributed to favorable reimbursement scenario in the US, rising incidence of cancer, increasing investments by hospitals to purchase new neuroendoscopic equipment, increasing research activities, and implementation of a new funding model for Canadian hospitals.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=68126508
The Neuroendoscopy Industry includes various small and large players. Key players in this market are KARL STORZ (Germany), B.Braun Aesculap (Germany), Ackermann Instrumente (Germany), Adeor Medical (Germany), Hawk (China), Machida (Japan), Tonglu Wanhe Medical (China), Schindler (Germany), Clarus (US), LocaMed (UK), and Visionsense (US).
According to GLOBOCAN 2012, the brain and nervous system cancer incidence rate was expected to increase by 6.6% from 2012 to 2015, globally. Similarly, according to the Global Burden of Disease Study 2015, neurological disorders were ranked as the leading cause group for disability-adjusted life-years (DALYs) in 2015 (approximately 250.7 million DALYs or 10.2% of global DALYs) and the second-leading cause group for deaths (~9.4 million or 16.8% of global deaths). Between 1990 and 2015, the number of deaths from neurological disorders increased by 36.7%, and the number of DALYs by 7.4%. As a result of the rising burden of neurological disorders, the number of neurosurgical procedures is growing across the globe.
MarketsandMarkets™
Mr. Aashish Mehra
1-888-600-6441
raviraj.tak@marketsandmarkets.com
Source: EmailWire.Com 
|
